Approval · Notice of Compliance 5406 · 2004
OXYCONTIN: Notice of Compliance 5406
Issued September 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5406
- Date
- September 23, 2004
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 5mg tablets
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYCONTIN | 02258129 | Cancelled Post Market |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 5 MG per TAB